Menostar Berlex - Treatment for Osteoporosis Prevention
Menostar is a clear, dime-sized, once-a-week patch that delivers half the dose (only 14 micrograms per day) of the lowest currently available dose of transdermal estrogen therapy for post-menopausal osteoporosis prevention.Posted: June 2004
Menostar (estradiol transdermal system) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.